285 related articles for article (PubMed ID: 9656199)
1. [Treatment of aggressive non-Hodgkin's lymphomas].
López A; Palacio C
Med Clin (Barc); 1998 May; 110(16):614-8. PubMed ID: 9656199
[No Abstract] [Full Text] [Related]
2. Indications for early autologous stem cell transplantation in aggressive lymphoma.
Kluin-Nelemans HC
Ann Hematol; 2001; 80 Suppl 3():B121-2. PubMed ID: 11757692
[No Abstract] [Full Text] [Related]
3. [Diagnosis and treatment of Hodgkin's lymphoma (HL) in children].
Kolygin BA
Vopr Onkol; 2002; 48(3):269-73. PubMed ID: 12455347
[No Abstract] [Full Text] [Related]
4. [High-dose chemotherapy with bone marrow transplantation in recurrent or refractory NHL].
Torello E; Koziner B
Sangre (Barc); 1993 Dec; 38(6):473-80. PubMed ID: 7909622
[No Abstract] [Full Text] [Related]
5. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcome.
Fanin R; Sperotto A; Ruiz De Elvira C; Zaja F; Stocchi R; Geromin A; Cerno M; Patriarca F; Fanni Canelles M; Damiani D; Baccarani M
Haematologica; 2000 Sep; 85(9):943-51. PubMed ID: 10980633
[TBL] [Abstract][Full Text] [Related]
8. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
9. [Autologous bone marrow transplantation as early therapy for patients with aggressive non-Hodgkin's lymphoma].
Havemann K; Kaiser U
Strahlenther Onkol; 1996 Jan; 172(1):50-1. PubMed ID: 8571191
[No Abstract] [Full Text] [Related]
10. Tandem high-dose therapy followed by autologous stem-cell transplantation for refractory or relapsed high grade non-Hodgkin's lymphoma with poor prognosis factors: a prospective pilot study.
Le Gouill S; Moreau P; Morineau N; Harousseau JL; Milpied N
Haematologica; 2002 Mar; 87(3):333-4. PubMed ID: 11869953
[TBL] [Abstract][Full Text] [Related]
11. Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients.
Ruiz-Soto R; Sergent G; Gisselbrecht C; Larghero J; Ertault M; Hennequin C; Manson J; de Kerviler E; Briere J; Mounier N
Cancer; 2005 Dec; 104(12):2735-42. PubMed ID: 16284986
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Zinzani PL; Tani M; Molinari AL; Stefoni V; Zuffa E; Alinari L; Gabriele A; Bonifazi F; Salvucci M; Tura S; Baccarani M
Haematologica; 2002 Aug; 87(8):816-21. PubMed ID: 12161357
[TBL] [Abstract][Full Text] [Related]
13. Diffuse aggressive lymphomas: a curable subset of non-Hodgkin's lymphomas.
Skarin AT
Semin Oncol; 1986 Dec; 13(4 Suppl 5):10-25. PubMed ID: 2432666
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of treatment of recurrences of non-Hodgkin's lymphoma after combined chemoradiotherapy depending on prognostic indicators].
Kruglova GV; Finogenova IA
Vopr Onkol; 2001; 47(6):748-51. PubMed ID: 11826503
[TBL] [Abstract][Full Text] [Related]
15. High-dose therapy for aggressive non-Hodgkin's lymphoma.
Pettengell R
Br J Hosp Med; 1996 Nov 20-Dec 10; 56(10):521-4. PubMed ID: 8958405
[No Abstract] [Full Text] [Related]
16. [Autologous transplantation of peripheral blood stem cells in malignant lymphomas].
Sánchez Luceros A; Koziner B
Medicina (B Aires); 1995; 55(4):366-72. PubMed ID: 8728879
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.
Vranovsky A; Ladicka M; Lakota J
Neoplasma; 2008; 55(2):107-12. PubMed ID: 18652043
[TBL] [Abstract][Full Text] [Related]
19. Intensified induction followed by high-dose therapy with autologous peripheral blood stem cell support in poor-prognosis aggressive non-Hodgkin's lymphoma: results of a pilot study.
Choi SJ; Ryoo BY; Lee SS; Park Y; Kim BS; Kang YK
Haematologica; 2002 May; 87(5):555-7. PubMed ID: 12010675
[No Abstract] [Full Text] [Related]
20. [Non-Hodgkin's lymphoma in adults. Therapeutic strategy].
Le Bourgeois JP; Reyes F
Bull Cancer Radiother; 1996; 83(4):258-64. PubMed ID: 9081324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
